Crossmark

Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy

Crossref DOI link: https://doi.org/10.1038/EYE.2016.46

Published: 2016-06

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Wilde, C

Lakshmanan, A

Patel, M

Morales, M U

Dhar-Munshi, S

Amoaku, W M K
License Information

Text and Data Mining valid from 2016-04-01
More Information

Article History

Received: 2 October 2015

Accepted: 21 January 2016

First Online: 1 April 2016

Competing interests

: Professor Winfried Amoaku, MBChB, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Alcon Laboratories, Inc.; Alimera Sciences; Allergan, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer Inc; Roche; ThromboGenics, Inc. Served as a speaker or a member of the speaker's bureau for: Alimera Sciences; Allergan, Inc.; Novartis Pharmaceuticals Corporation; Pfizer. Received grants for clinical research from: Allergan, Inc.; CenterVue; Novartis Pharmaceuticals Corporation; Pfizer. Other (Educational Travel Grants): Allergan, Inc.; Bayer HealthCare Pharmaceuticals; Novartis Pharmaceuticals Corporation. The remaining authors declare no conflict of interest.